On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.
A recent study from researchers at Wake Forest University School of Medicine and Rutgers University shows a high rate of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback